Candel Therapeutics, Inc. CADL Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s increase (decrease) in other operating assets?
- Candel Therapeutics, Inc. (CADL) reported increase (decrease) in other operating assets of $21K in Q1 2026.
- How has Candel Therapeutics, Inc.'s increase (decrease) in other operating assets changed year-over-year?
- Candel Therapeutics, Inc.'s increase (decrease) in other operating assets increased by 520.0% year-over-year, from -$5K to $21K.
- What is the long-term trend for Candel Therapeutics, Inc.'s increase (decrease) in other operating assets?
- Over 2 years (2023 to 2025), Candel Therapeutics, Inc.'s increase (decrease) in other operating assets has grown at a -54.5% compound annual growth rate (CAGR), from $116K to $24K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.